Thomas Richard Kassberg - Dec 31, 2021 Form 5 Insider Report for Ultragenyx Pharmaceutical Inc. (RARE)

Role
CBO & EVP
Signature
/s/ Karah Parschauer, attorney-in-fact
Stock symbol
RARE
Transactions as of
Dec 31, 2021
Transactions value $
$0
Form type
5
Date filed
2/1/2022, 12:42 PM
Previous filing
Oct 18, 2021
Next filing
Mar 3, 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RARE Common Stock Gift $0 -52 -0.02% $0.00 216K Dec 10, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.